Alternative, especially preferred pharmaceutical compositions embodying the present invention are those comprising leuprolide acetate in a concentration of between 0.5% and 2% by weight, Labrafac??? in a concentration of between 0.2% and 1% by weight, aspartame in a concentration of about 0.1% by weight, and menthol in a concentration of about 0.05% by weight.